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CLINICAL
REHABILITATION
Dynamic Lycra® orthoses as an 
adjunct to arm rehabilitation 
after stroke: a single-blind, two-
arm parallel group, randomized 
controlled feasibility trial
Jacqui H Morris1 , Alexandra John1,  
Lucy Wedderburn2, Petra Rauchhaus3 and  
Peter T Donnan4
Abstract
Objective: The aim of this study was to explore the feasibility of conducting a randomized controlled 
trial of dynamic Lycra® orthoses as an adjunct to arm rehabilitation after stroke and to explore the 
magnitude and direction of change on arm outcomes.
Design: This is a single-blind, two-arm parallel group, feasibility randomized controlled trial.
Setting: In-patient rehabilitation.
Subjects: The study participants were stroke survivors with arm hemiparesis two to four weeks after 
stroke receiving in-patient rehabilitation.
Interventions: Participants were randomized 2:1 to wear Lycra® gauntlets for eight hours daily for 
eight weeks, plus usual rehabilitation (n = 27), or to usual rehabilitation only (n = 16).
Main measures: Recruitment, retention, fidelity, adverse events and completeness of data collection 
were examined at 8 and 16 weeks; arm function (activity limitation; Action Research Arm Test, Motor 
Activity Log) and impairment (Nine-hole Peg Test, Motricity Index, Modified Tardieu Scale). Structured 
interviews explored acceptability.
Results: Of the target of 51, 43 (84%) participants were recruited. Retention at 8 weeks was 32 (79%) 
and 24 (56%) at 16 weeks. In total, 11 (52%) intervention group participants and 6 (50%) control group 
participants (odds ratio = 1.3, 95% confidence interval = 0.2 to 7.8) had improved Action Research 
Arm Test level by 8 weeks; at 16 weeks, this was 8 (61%) intervention and 6 (75.0%) control participants 
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(odds ratio = 1.1, 95% confidence interval = 0.1 to 13.1). Change on other measures favoured control 
participants. Acceptability was influenced by 26 adverse reactions.
Conclusion: Recruitment and retention were low, and adverse reactions were problematic. There were 
no indications of clinically relevant effects, but the small sample means definitive conclusions cannot be 
made. A definitive trial is not warranted without orthoses adaptation.
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Introduction
Studies with children who have spastic hemiplegia 
caused by cerebral palsy suggest that wearing 
dynamic Lycra® orthoses as an adjunct to goal-
directed training may improve movement and 
functional goal achievement.1 This evidence raises 
the question of whether the orthoses may be effec-
tive as an adjunct to rehabilitation in adults with 
arm impairments after stroke. Arm impairments, 
which include weakness and sensory loss, restrict 
independence in activities of daily living and affect 
stroke survivors’ quality of life.2
Dynamic Lycra® orthoses are commercially 
available dynamic braces that use tensile properties 
of Lycra®  to generate torsion, correct muscle force 
imbalances across joints, optimize muscle length 
and functional positioning, and provide compres-
sion to enhance proprioception and sensory aware-
ness.3,4 However, effectiveness in stroke 
rehabilitation has not been fully evaluated, despite 
anecdotal evidence that they are already in use in 
clinical practice. One single case study of 6 weeks 
wear in a survivor with long-standing stroke4 and a 
crossover trial with 16 stroke survivors 3–36 weeks 
after stroke onset3 involving only 3 hours orthosis 
wear have shown improvements in arm impair-
ment, sensation and functional outcomes after 
orthosis wear. Evidence is therefore limited to low-
quality study designs, and rigorous effectiveness 
studies are required.
The aim of this feasibility randomized con-
trolled trial was to examine recruitment, retention, 
adverse events, intervention fidelity, magnitude 
and direction of difference in outcomes in stroke 
survivors receiving Lycra® orthoses as an adjunct 
to usual rehabilitation, compared to those receiving 
usual rehabilitation only. It also aimed to explore 
survivor and carer perceptions of acceptability, to 
inform decisions about a future definitive rand-
omized controlled trial.
Methods
This was a single-blind, two-arm parallel group, 
feasibility randomized controlled trial. The study 
was funded by the Chief Scientist Office at the 
Scottish Government (grant no. CZH/4/1075). 
Tayside Clinical Trials Unit was responsible for 
oversight of study conduct and governance, and 
East of Scotland Research Ethics Committee pro-
vided ethical approval (ref. no. 15/ES/0093). The 
trial was registered with ClinicalTrials.gov (identi-
fier: NCT03063970). Recruitment was conducted 
between March and December 2017, with final 
follow-up assessment in March 2018.
Participants were recruited from two acute 
stroke units in the North East of Scotland. 
Eligibility criteria were as follows: stroke survi-
vors two to four weeks after unilateral ischaemic 
stroke; persistent arm activity limitation indicated 
by Action Research Arm Test (ARAT) scores ⩽45 
(maximum = 57);5 and able to participate in usual 
rehabilitation. Exclusion criteria were as follows: 
inability to provide informed consent, previous 
stroke resulting in residual disability, hemiplegic 
shoulder pain, Lycra® sensitivity, premorbid arm 
impairment or already using arm orthoses. A sam-
ple of 51 subjects was judged adequate to provide 
information about potential effects and variance to 
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inform sample size calculations for a future defini-
tive trial.6
Regular rehabilitation therapists identified 
potential participants from stroke unit admission 
records and provided them with study invitation 
materials. Stroke survivors expressing interest in 
participation provided written permission to be 
contacted by a researcher. The study researcher 
(A.J.) then visited participants, explained the study 
and obtained informed consent for study participa-
tion before undertaking eligibility screening, fol-
lowed by baseline assessment and randomization.
Randomization to intervention or usual rehabili-
tation control groups was undertaken in a 2:1 ratio 
to optimize information collected about the inter-
vention in this small feasibility study. After screen-
ing and baseline assessment, the study researcher 
entered participant study identification number and 
minimization information into an electronic pass-
word-protected remote, concealed, web-based ran-
domization system developed for the study by 
Tayside Clinical Trials Unit. Minimization was 
applied by severity level of activity limitation on 
ARAT scores.5 Levels were previously defined by 
examining Nine-hole Peg Test7 and ARAT scores 
together, with scores of severe 0–3 indicating little 
or no movement, Moderate 4–28 indicating some 
movement but limited dexterity, defined by inabil-
ity to place pegs in the Nine-hole Peg Test and mild 
⩾29 indicating ability to place one or more pegs in 
the Nine-hole Peg Test.8 The computerized system-
generated random sequence allocation determined 
group allocation and the study occupational thera-
pist (L.W.) was then informed by the researcher of 
participant group allocation.
Demographic data were collected at baseline and 
included gender, age and time from stroke onset to 
randomization. Stroke type and lesion location were 
determined by review of computerized tomography 
scans with a specialist neuro-radiology consultant. 
Other data describing participant characteristics 
included stroke severity, measured by the National 
Institute of Health Stroke Scale,9 cognitive function 
measured on the Montreal Cognitive Assessment,10 
handedness measured on the Edinburgh Handedness 
Inventory11 and independence in activities of daily 
living measured on the Barthel Index.12
Baseline data were collected by the trained 
study researcher (zero weeks). At eight weeks, out-
come data were collected from all participants and 
the orthosis was removed from intervention group 
participants. At 16 weeks follow-up, data were col-
lected to assess long-term duration of any effects. 
Data were collected by a blinded assessor, a neuro-
physiotherapist trained in outcome assessment, in 
hospital or in participants’ homes if they had been 
discharged. The nature of the intervention, an 
orthosis that was worn and applied by staff or 
patients themselves, meant participants and reha-
bilitation therapists could clearly see which group 
the participant was allocated to. This meant that 
neither participants nor rehabilitation therapists 
could be blinded to intervention allocation.
Outcomes were as follows:
•• Data on recruitment, screening and randomiza-
tion rates collected from stroke unit admission 
data;
•• Retention rate at 8 and 16 weeks;
•• Adverse events reported by participants or 
staff;
•• Wear fidelity recorded by participants and their 
families in daily diaries;
•• Activity limitation (ARAT);5
•• Arm strength (Motricity Index);13
•• Grip strength (Jamar Plus digital hand-held 
dynamometer);14
•• Fine manual dexterity (Nine-hole Peg Test cal-
culated in seconds/peg placed);15
•• Elbow spasticity quantified by differences in 
angles of muscle reaction with fast and slow 
stretch (Modified Tardieu Scale);16
•• Light touch perception at fingers, hand, fore-
arm and arm, and proprioception at thumb, 
wrist, elbow and shoulder (Erasmus Modified 
Nottingham Sensory Assessment);17
•• Patient-reported arm activity (Motor Activity 
Log 14).18
Participants randomized to the intervention 
group were visited by the study occupational thera-
pist to measure the arm, prescribe and fit the ortho-
sis. The occupational therapist was an experienced 
clinician with more than 20 years of neurological 
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rehabilitation experience. She was trained in ortho-
sis measurement and fitting through attendance at 
the manufacturer’s training course and had many 
years’ experience of measuring and fitting orthoses 
in clinical practice, in collaboration with manufac-
turers’ orthotists. She also had additional training 
with the manufacturer’s orthotist in preparation for 
the study. In addition, the manufacturer’s orthotist 
provided advice and guidance on measurement, fit-
ting and adaptations as required throughout the 
study. To ensure measurement and fitting accuracy, 
the orthotist, or another health professional, 
assisted during orthotic measurement procedures. 
Where possible, and according to manufacturers’ 
instructions, measurements were conducted in the 
middle of the day to account for fluctuations in 
oedema first thing in the morning and later in the 
day.
To optimize cutaneous and proprioceptive sen-
sory stimulation and control of movement, maxi-
mum limb coverage by the orthosis was considered 
appropriate. During the piloting phase prior to this 
feasibility randomized controlled trial, gauntlet 
and short-fingered glove dynamic Lycra® orthoses 
designs were tested for acceptability and feasibility 
with 17 stroke survivors who met inclusion criteria 
for the randomized controlled trial. Participants 
reported difficulties doffing and donning the glove, 
compared to the gauntlet, with restrictions to dex-
terity, discomfort and blistering at the thumb web 
reported with glove wear. It was decided that the 
gauntlet design was most acceptable and feasible 
for use in the randomized controlled trial. The 
gauntlet extended from metacarpophalangeal joints 
to deltoid insertion, encompassing thumb metacar-
pophalangeal joint, wrist and elbow joints (Figure 1). 
The pilot study is in submission for publication 
elsewhere.
Several visits for measurement, fitting and 
adjustment were required, therefore an additional 
week for gradual increase in wear duration to eight 
hours per day was incorporated into trial flow, to 
accommodate adjustments and allow acclimatiza-
tion to wear. After this week, participants wore the 
orthosis for eight hours daily for eight weeks, to 
support motor control and provide continuous sen-
sory stimulation during task practice and perfor-
mance throughout the day, giving a total 
intervention period of nine weeks. In the absence 
of definitive research about wear duration in this 
population, eight hours per day was determined by 
the manufacturer’s seven-day wear protocol for 
Lycra® garments19 and through discussion with the 
manufacturer’s orthotist.
The study team made adaptations to the 
dynamic Lycra® orthoses as necessary throughout 
Figure 1. Example of Lycra® gauntlet used in the study.
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the intervention period to ensure fit, comfort and 
duration of wear while remaining compatible with 
the study protocol. Participants, nurses, rehabilita-
tion professionals and family members were 
trained in donning and doffing the orthosis, in 
checking for oedema or other skin and circulatory 
problems and received written instruction leaflets 
to support their training. Piloting highlighted that 
some participants presented with or developed 
upper limb and hand oedema. Intervention group 
participants and their carers were therefore 
instructed to contact the research occupational 
therapist immediately should problems of com-
fort, fit or oedema arise that prevented wear.
Participants developing oedema were provided 
with a graduated compression oedema glove to 
wear overnight and with the dynamic Lycra® 
orthoses. This was to reduce the likelihood of oedema 
preventing dynamic Lycra® orthoses wear, or the 
onset of skin and circulatory problems. Where 
oedema occurred, the occupational therapist would 
provide the oedema compression glove and moni-
tor oedema, fit and comfort. If oedema glove provi-
sion was not appropriate or not effective, she would 
next involve the study orthotist to advise on adap-
tations to the dynamic Lycra® orthosis. When this 
happened, the orthosis was sent for adjustment and 
the participant restarted the intervention and con-
tinued wear until the eight weeks total duration of 
wear was complete.
After randomization, both groups received an 
information leaflet about general care of the 
hemiplegic arm. Intervention group participants 
were also asked to complete a diary to record 
daily frequency and duration of wear. During the 
eight-week intervention period, the occupational 
therapist telephoned all participants at four weeks 
to explore progress, identify problems and main-
tain interest in the study. Apart from the telephone 
call at four weeks, the control group received no 
additional intervention. Both groups received 
usual rehabilitation, typically 45 minutes of occu-
pational and physiotherapy per weekday. For par-
ticipants discharged home during the study, 
rehabilitation typically comprised one session 
each of physiotherapy or occupational therapy 
per week.
Rehabilitation therapists were asked to com-
plete diaries to record usual rehabilitation duration 
and content for intervention and control group par-
ticipants. To record usual therapy in a standardized 
way, therapists were provided with a list of ther-
apy interventions, identified in the pilot study as 
representing usual practice, and asked to record 
time spent in each per session and number of rep-
etitions. Interventions included activities of daily 
living, range of movement, task training, weight-
bearing, hands on therapy, stretching and position-
ing, strengthening, mental practice and mirror 
therapy.
Data analysis
Descriptive analysis, calculating number and per-
centage, was conducted for recruitment, retention 
and adverse event rates. Proportion of missing data 
was examined to inform outcome measure selec-
tion for a definitive trial. Definitive hypothesis 
testing was not conducted; however, between-
group comparison was undertaken to explore dif-
ference in magnitude and direction of change. 
Analysis was by intention-to-treat. Primary analy-
sis involved group comparison for change in out-
come between baseline, and 8 and 16 weeks, 
adjusted for baseline scores and severity of activity 
limitation, derived from baseline ARAT scores. 
Continuous outcomes were assessed for normality, 
and relevant transformations were made. Repeated 
measures analysis was performed, and outcomes 
were assessed by multiple linear regression to give 
mean difference (95% confidence interval (CI)). 
Continuous data that could not be transformed to 
normal distribution were translated to binary out-
comes and analysed using logistic regression. 
Categorical data were assessed using logistic 
regression to provide an odds ratio (95% CI).
Post-study interviews
A total of 12 orthosis group participants agreed to 
participate in interviews at 16 weeks with their car-
ers or family members, to explore experiences of 
study participation. Interviews were guided by a 
topic guide (Supplemental material), examining 
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benefits, limitations, acceptability and feasibility 
of orthosis wear and experiences of trial participa-
tion. Transcripts were read, coded and thematically 
analysed by two study researchers (A.J. and 
J.H.M.) experienced in qualitative methods.
Results
A total of 43 participants were recruited. Age 
ranged between 23 and 86 years, of which 24 par-
ticipants (56%) were male. Participant characteris-
tics and baseline scores for each group are presented 
in Table 1. The 2:1 randomization strategy worked, 
and groups were similar at baseline.
Participant flow through the study is presented 
in Figure 2. Median recruitment rate per month 
was 4 (range = 1–8) and the sample size of 43 
was 84% of the anticipated target (n = 51). At 8 
weeks, study retention for the intervention group 
was 81.5% and at 16 weeks, 55.6%; for the control 
group, these rates were and 75% and 56.3% 
respectively. Of five intervention group withdraw-
als before eight weeks, two involved serious 
adverse events unrelated to the intervention; 
Table 1. Participant characteristics.
Intervention
group (N = 27)
Control group (N = 16)
Sex, n (%)
 Male 13 (48.1) 11 (68.8)
 Female 14 (51.9) 5 (31.3)
Age (years), mean (SD) 67.2 (16.67) 67.3 (10.14)
Time post-stroke to randomization (days), mean (SD) 22.6 (4.1) 19.9 (5.0)
Montreal Cognitive Assessment score, mean (SD)
(max = 30, indicating full cognitive function)
20.3 (7.64) 20.6 (7.36)
NIH Stroke Scale, mean (SD)
(max = 42, indicating severe stroke)
5.4 (3.24) 4.3 (2.41)
Location of stroke, n (%)
 Anterior circulation cortical 13 (48.1) 8 (50.0)
 Anterior circulation subcortical 7 (25.9) 4 (25.0)
 Posterior circulation cortical 1 (3.7) 1 (6.3)
 Posterior circulation subcortical 6 (22.2) 3 (18.8)
Type of stroke, n (%)
 Haemorrhagic 4 (14.8) 2 (12.5)
 Ischaemic 23 (85.2) 14 (87.5)
Hemiplegic side, n (%)
 Left 14 (51.9) 8 (50.0)
 Right 13 (48.1) 8 (50.0)
Edinburgh Handedness Inventory, n (%)
 Missing 1 (3.7) 1 (6.3)
 Left 2 (7.4) 1 (6.3)
 Right 24 (88.9) 14 (87.5)
Barthel Index Score 63.9 (23.4) 72.1 (22.8)
ARAT baseline score, mean (SD)
(max = 57, indicating good arm function)
23.3 (20.5) 23.7 (20.44)
Severe activity limitation (ARAT = 0–3), n (%) 7 (25.9) 5 (31.3)
Moderate activity limitation (ARAT = 4–28), n (%) 10 (37.0) 5 (31.3)
Mild activity limitation (ARAT > 29), n (%) 10 (37.0) 6 (37.5)
SD, standard deviation; NIH, National Institute of Health; ARAT, Action Research Arm Test.
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Figure 2. Participant flow through the study.
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however, three withdrawals involved arm pain, 
swelling and discomfort that were related to 
orthosis wear. The 24 further adverse reactions 
linked to orthosis wear included skin irritation 
(n = 4), hand oedema (n = 9), discomfort (n = 7), 
restricted movement (n = 2), paraesthesia (n = 1) 
and finding the orthosis too warm (n = 1). These 
did not cause study discontinuation.
Daily orthosis wear was recorded in diaries by 
intervention group participants, carers or health pro-
fessionals. In total, 20 (77%) diaries were returned, 
of which only 5 (25%) had entries for the planned 
56 days of the intervention. Of those, three partici-
pants (60%) reported data for every day. Across 
returned diaries, median duration of daily wear was 
8 hours (range = 3–9) over 28 (range = 0–56) days. 
Usual rehabilitation was poorly recorded, with 
only 17 of 43 (40%) diaries returned across the 
sample, with 12 diaries (44%) returned for the 
intervention group and 4 (33%) for the control 
group. The median (range) number of entries com-
pleted by rehabilitation therapists per participant 
Table 2. Outcome scores at baseline (0 weeks), 8 weeks and 16 weeks: mean (SD), median (range).
Variable Visit 
(weeks)
Intervention group (N = 27) Control group (N = 16)
N Mean (SD) Median (range) N Mean (SD) Median (range)
Action Research Arm Test total score
(maximum score = 57)
0 27 23.3 (20.5) 25.0 (0–57) 15 23.7 (20.44) 22.0 (0–53)
8 21 32.0 (24.3) 39.0 (0–57) 12 38.3 (21.92) 50.5 (3–57)
16 13 34.0 (26.5) 47.0 (0–57) 8 47.4 (15.28) 53.5 (11–57)
Nine-hole Peg Test
(seconds per peg)
0 11 36.5 (53.7) 5.6 (2–120) 7 29.3 (41.97) 15.0 (3–120)
8 12 11.9 (15.2) 2.7 (1–40) 9 7.7 (9.11) 3.5 (2–30)
16 8 6.6 (9.7) 2.5 (2–30) 7 3.9 (2.13) 3.5 (2–9)
Modified Tardieu Scale
R1 angle of catch fast stretch
Elbow extension
0 27 160.9 (25.5) 180.0 (120–180) 7 153.3 (37.2) 180.0 (70–180)
8 22 155.7 (30.3) 172.5 (90–180) 9 166.7 (21.5) 180.0 (120–180)
16 13 152.3 (39.1) 180.0 (80–180) 7 173.8 (14.1) 180.0 (140–180)
Modified Tardieu Scale
R2 angle of catch slow stretch
Elbow extension
0 27 178.1 (7.9) 180.0 (140–180) 7 177.3 (5.6) 180.0 (165–180)
8 22 174.1 (13.6) 180.0 (130–180) 9 174.2 (12.4) 180.0 (140–180)
16 13 169.6 (20.5) 180.0 (120–180) 7 173.8 (14.8) 180.0 (140–180)
Modified Tardieu Scale
Spasticity angle R2-R1
Elbow extension
0 27 17.2 (24.9) 0.0 (0–80) 15 24.0 (35.6) 0.0 (0.0–110.0)
8 22 18.4 (26.2) 0.0 (0–90) 12 7.5 (14.2) 0.0 (0.0–40.0)
16 13 17.3 (30.0) 0.0 (0–100) 8 0.0 (0.0) 0.0 (0.0–0.0)
Motricity Index total arm score
(maximum score = 100)
0 27 56.5 (31.8) 62.0 (1–100) 15 63.9 (26.96) 71.0 (1–93)
8 22 65.1 (31.5) 80.5 (1–100) 11 80.5 (24.39) 85.0 (34–100)
16 13 65.3 (35.4) 84.0 (1–100) 7 94.4 (7.39) 100.0(84–100)
Mean grip strength (kg) 0 27 6.5 (6.4) 6.7 (0–22) 15 8.3 (7.9) 6.7 (0–27)
8 22 10.3 (10.1) 7.0 (0–34) 12 13.7 (10.2) 15.6 (0–28)
16 13 11.4 (11.1) 8.4 (0–35) 8 18.7 (9.8) 19.2(5–32)
MAL 14 mean amount scale
(maximum score = 5)
0 27 1.1 (1.2) 0.6 (0–5) 15 1.0 (1.0) 1.0 (0–3)
8 22 1.8 (1.7) 1.5 (0–5) 12 2.1 (1.8) 1.6 (0–5)
16 13 2.1 (2.0) 2.1 (0–5) 8 3.1 (1.9) 3.3(1–5)
MAL 14 mean how well
(score = 5)
0 27 0.8 (1.0) 0.5 (0–4) 15 0.8 (0.8) 0.5 (0–3)
8 22 1.5 (1.5) 1.4 (0–5) 12 1.8 (1.5) 1.5 (0–4)
16 13 1.9 (1.8) 2.0 (0–5) 8 2.9 (1.6) 3.2 (1–5)
EmNSA total score touch
(maximum score = 8)
0 27 4.8 (3.21) 6.0 (0–8) 15 4.7 (1.8) 5.0 (2–8)
8 22 6.3 (2.83) 8.0 (0–8) 12 7.3 (1.8) 8.0 (3–8)
16 13 6.4 (2.99) 8.0 (0–8) 8 6.8 (1.8) 8.0 (4–8)
EmNSA total score proprioception
(maximum score = 8)
0 27 6.9 (2.4) 8.0 (0–8) 15 7.7 (0.5) 8.0 (7–8)
8 22 7.5 (1.79) 8.0 (0–8) 12 7.9 (0.3) 8.0 (7–8)
16 13 7.8 (0.83) 8.0 (5–8) 8 8.0 (0.0) 8.0 (8–8)
MAL, Motor Activity Log; EmNSA, Erasmus Modified Nottingham Sensory Assessment.
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was 6.5 (1–44), and for the control group, this was 
4.0 (2–6). Most diaries reported time spent rather 
than repetitions of usual therapy interventions, and 
most reported only a small selection of the identi-
fied interventions. Of those usual therapy interven-
tions reported by both groups, median (range) 
minutes spent by intervention and control groups 
respectively, were as follows: range of movement, 
15 (3–60) versus 10 (5–20) minutes; task training, 
10 (15–2) versus 30 (0–30) minutes; hands on ther-
apy, 10 (3–40) versus 5 (0–5) minutes; stretching 
and positioning, 20 (3–60) versus 10 (10–15) 
minutes; strengthening, 12.5 (5–20) versus 7.5 (5–
10) minutes; and mental practice, 20 (10–30) ver-
sus 5 (0–5) minutes.
Descriptive data for baseline, and 8- and 16-week 
outcome scores (mean (SD)), median (range) are 
shown in Table 2. By 8 and 16 weeks, the control 
group demonstrated higher scores on all meas-
ures. Change from baseline (zero weeks) and 
exploratory logistic regression analysis are shown 
in Table 3. ARAT, Nine-hole Peg Test and Modified 
Tardieu Scale spasticity angle data were skewed 
and could not be transformed to normal 
Table 3. Between-group differences in change, 0–8 and 0–16 weeks: adjusted odds ratio/mean difference (95% CI).
Outcome Change
(weeks)
Intervention group Control group Between-group 
differencea,b,c
N Change (n, % or 
mean, 95% CI)
N Change (n, % or 
mean, 95% CI)
Adjusted odds ratio/
mean difference (95% CI)
Action Research Arm 
Test level
(n, % improved by 1 or 
more ARAT severity 
level)
0–8
0–16
21
13
11 (52.0%)
8 (61.5%)
12
8
6 (50.0%)
6 (75.0%)
1.3 (0.2 to 7.8)a
1.1 (0.1 to 13.1)a
Nine-hole Peg Test
(n, % improved from 
unable to able to place 
nine pegs)
0–8
0–16
22
13
12 (54.5%)
8 (61.5%)
12
8
9 (75.0%)
7 (87.5%)
0.3 (0.0 to 5.6)a
1.0 (< 0.001)a
Modified Tardieu Scale
Spasticity angle
(n, % improved to 
have spasticity angle at 
elbow = 0)
0–8
0–16
22
13
12(54.1%)
8 (61.5%)
12
8
9 (75.0%)
8 (100.0%)
0.2 (0.01 to 4.4)a
< 0.001 (< 0.001)a
Motricity Index
(maximum score = 100)
0–8
0–16
22
13
12.1 (6.9 to 17.3)
14.0 (2.1 to 25.9)
11
7
16.7 (9.9 to 23.5)
17.4 (7.3 to 27.6)
−6.2 (−13.8 to 1.4)b
−4.7 (−18.1 to 8.8)b
Grip strength (kg) 0–8
0–16
22
13
4.0 (1.5 to 6.4)
6.0 (1.8 to 10.1)
12
8
5.5 (1.9 to 9.1)
10.9 (5.4 to 16.4)
−1.5 (−5.5 to 2.4)b
−3.2 (−9.6 to 3.3)b
MAL 14 total amount
(maximum score = 5)
0–8
0–16
22
13
0.8 (0.4 to 1.2)
0.9 (0.2 to 1.6)
12
8
1.0 (0.1 to 1.8)
1.8 (0.7 to 2.9)
−0.1 (−0.7 to 0.6)b
−0.5 (−1.6 to 0.5)b
MAL 14 total how well
(maximum score = 5)
0–8
0–16
22
13
0.8 (0.5 to 1.1)
0.9 (0.4 to 1.4)
12
8
1.0 (0.4 to 1.6)
1.8 (0.8 to 2.8)
−0.1 (−0.6 to 0.3)b
−0.6 (−1.4 to 0.3)b
EmNSA total score touch 
(maximum score = 8)
0–8
0–16
22
13
0.0 (0.0 to 2.0)
0.0 (0.0 to 2.0)
12
8
2.5 (1.0 to 4.0)
2.5 (1.5 to 3.5)
−1.1 (−0.4 to 0.1)c
−0.1 (−0.1 to 0.3)c
EmNSA total score 
proprioception
(maximum score = 8)
0–8
0–16
22
13
0.0 (0.0 to 0.0)
0.0 (0.0 to 0.0)
12
8
0.0 (0.0 to 0.5)
0.0 (0.0 to 0.5)
−0.01 (−0.06 to 0.05)c
−0.02 (−0.10 to 0.06)c
MAL, Motor Activity Log; EmNSA, Erasmus Modified Nottingham Sensory Assessment.
aDifference is odds ratio derived from logistic regression.
bMean difference is derived from linear regression adjusted for baseline value and minimization variable ARAT.
cMean difference is derived from linear regression and gamma distribution.
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distribution. Data were therefore translated to 
binary outcomes, defined as improvement in one or 
more ARAT severity level; improvement from una-
ble to able to place nine pegs; and change to 0 on 
Modified Tardieu Scale spasticity angle (defined as 
R2 angle of catch on slow stretch minus R1 angle 
of catch on fast stretch), indicating no spasticity.
The proportion of participants improving ARAT 
severity level zero to eight weeks was higher in the 
intervention group (n = 11, 52%) compared to the 
control group (n = 6, 50%) by a small margin that 
was reflected in the adjusted odds ratio (Table 3). 
However, for change 0–16 weeks, the proportion of 
participants improving ARAT severity level was 
higher in the control group (n = 6, 75%) compared 
to the intervention group (n = 8, 61%). For the Nine-
hole Peg Test and the Modified Tardieu Scale, the 
proportion of participants improving level of peg 
placement and spasticity angle 0–8 and 0–16 weeks 
favoured the control group (Table 3). For adjusted 
mean difference in Motricity Index, grip strength, 
Motor Activity Log and Erasmus Nottingham 
Sensory Assessment, improvements favoured con-
trols (Table 3). Samples were small and confidence 
intervals large, therefore findings must be regarded 
cautiously; however, patterns suggest poorer 
dynamic Lycra® orthoses group performance.
The assessor was unblinded in 13 cases (31%), 
despite instructing participants not to disclose 
group allocation. All measures were fully com-
pleted at every assessment, indicating that missing 
data would not be problematic in a definitive trial.
Qualitative findings
A total of 12 intervention group participants and 
their carers were interviewed by a study researcher 
(A.J.) (Supplemental Appendix 1). Many partici-
pants reported improved confidence, support, limb 
awareness, limb alignment, strength, and control of 
muscle tone and movement (see Supplemental 
Appendix 1 for illustrative quotes). Other partici-
pants reported movement and circulation restriction, 
skin irritation and worsened oedema. Regardless of 
experiences, participants were content to complete 
outcome measures and comply with study steps to 
support the research. Study documentation and 
researcher explanations were perceived as clear. 
Clarity about study involvement, acceptance of 
screening, randomization and measurement was 
notable, as was appreciation of their personal con-
tribution as participants. Carers of these partici-
pants were supportive of the study and some noted 
positive outcomes from wear, specifically in par-
ticipant confidence undertaking certain activities, 
in providing support, reducing tone and increased 
awareness of the affected limb. They also per-
ceived disadvantages from orthosis wear as it could 
not be worn during certain exercises, in dirty tasks 
or any task involving water.
Discussion
This feasibility randomized controlled study of 
dynamic Lycra® orthoses in stroke showed a defin-
itive multicentred randomized controlled trial to 
examine effectiveness could be feasible, but 
recruitment and retention strategies require adapta-
tion. However, there was little indication that the 
orthoses might improve outcomes more than usual 
care, and adverse reactions were reported. 
Progression to randomized controlled trial may 
therefore not be warranted.
At 6% recruitment rate was low, but congruent 
with arm rehabilitation studies recruiting soon after 
stroke.8,20 Because study researchers recruited par-
ticipants in collaboration with local staff, we know 
most eligible participants were recruited. We antici-
pated recruiting around five participants per month 
over 10 months; however, slow recruitment, partic-
ularly in autumn months, meant this figure was 
lower. Consequently, we ran out of time to under-
take 16-week assessment for 4 intervention and 3 
control participants, contributing to low retention at 
16 weeks. A multicentre randomized controlled trial 
would require recruitment through local clinical 
staff, which would make recruitment slower, neces-
sitating realistic calculation of required sites, and a 
long recruitment period. During autumn, many 
stroke survivors were too ill to participate, which 
aligns with studies showing increased rates of major 
stroke subtypes in autumn.21 Our findings therefore 
provide a realistic estimation of recruitment and 
study timescales, from which to calculate sites for a 
definitive trial, while accounting for seasonal varia-
tion in recruitment.
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Study retention at 81% and 75% at eight weeks 
for intervention and control groups was low and 
had this been a definitive trial, would have threat-
ened study validity.22,23 Attrition due to ill-health 
was inevitable and requires consideration in sam-
ple estimation for a randomized controlled trial. 
Withdrawal with adverse intervention responses 
was problematic. Early pilot work showed prob-
lems with skin marking and oedema; therefore, we 
introduced adaptations – oedema gloves and gaunt-
let lengthening to reduce problematic oedema, and 
silk liners to prevent skin irritation. Despite subse-
quent adaptations, problems led to withdrawals. 
Other studies report adverse events of prolonged 
orthotic wear. Although involving rigid splints, in 
line with this study, incidents included skin break-
down, oedema and discomfort.24,25 Risks of 
adverse events have to be balanced against inter-
vention benefit; however, potential benefits of 
Lycra® orthoses remain uncertain. Reconsidering 
orthosis design and wear duration will be crucial 
before a definitive randomized controlled trial.
Three control group participants requested with-
drawal because of losing interest, a known phenom-
enon when there is no control intervention.20,26 We 
considered sham gauntlets, however previous 
research in multiple sclerosis found these required 
elastic characteristics, acting to an extent as an 
intervention.27 However, given effects on retention 
of no active control intervention, an acceptable but 
inert control intervention should be reconsidered.
Measurement bias potentially threatened our 
findings. The assessor, a physiotherapist also work-
ing in rehabilitation, was unintentionally unblinded 
at work six times. She was unblinded seven more 
times because participants disclosed group alloca-
tion. Educating participants more about maintain-
ing blinding and complete assessor independence 
will be vital in future.
Although low-quality design, previous Lycra® 
orthoses studies3,4 suggest improved spasticity, pro-
prioception and arm function; therefore, we antici-
pated some indications of benefit from wear. We 
found only slightly improved odds of improving 
ARAT severity level by eight weeks. Examining 
change in relatively arbitrary ARAT severity levels 
was somewhat crude but necessary because ARAT 
data were severely skewed. The approach probably 
masked important details, given unadjusted ARAT 
scores (Table 2) suggest higher outcome scores in 
the control group. Odds ratios and adjusted mean 
differences on other measures were neutral or 
favoured controls. There was therefore no sugges-
tion of potential benefit of Lycra® orthoses. Although 
we did not set decision rules about progression to 
trial, some indication of benefit would be necessary 
to justify progression. Small sample size, large vari-
ability and lack of definitive hypothesis testing 
means caution in interpretation has to be applied, but 
our data imply that benefits from Lycra® orthoses 
are unlikely, thus informing our judgement about 
progression to randomized controlled trial.
Previous literature and our pilot work sug-
gested that these orthoses may be beneficial.3,4 
The dynamic properties of Lycra® were assumed 
to enhance sensory awareness and joint alignment, 
potentially enhancing practice frequency and 
duration, to improve arm function.3,4 However, 
indications are they may act as static splints, 
immobilizing rather than facilitating function. A 
Cochrane Review examining stretch for treatment 
and prevention of contracture in neurological 
conditions24 shows that static orthoses have little 
or no impact on arm joint mobility or spasticity, 
and function, reflecting our findings. If Lycra® 
orthoses are to be pursued as an intervention after 
stroke, they need to be explicitly dynamic.28 
Undertaking a definitive randomized controlled 
trial is, thus, probably not warranted without sig-
nificant intervention redesign.
Although participants reported enhanced body 
schema and confidence, it would be ethically unac-
ceptable to further investigate an intervention that 
causes adverse reactions and poorer physical out-
comes, despite perceived benefits. However, out-
comes may reflect low wear fidelity. Diaries are 
poorly completed,29 and although we used and 
piloted a diary already optimized for completion,30 
our completion rates were low. Electronic monitor-
ing using accelerometers to determine wear fidelity 
could address this problem and would be vital in a 
future randomized controlled trial. Therapy diaries 
were poorly completed; however, data seem to sug-
gest that the intervention group received more ther-
apy across the eight-week period. Although this 
may reflect a Rosenthal effect on rehabilitation 
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activity and diary completion because of thera-
pists’ study participation and knowledge of group 
allocation,31 definitive conclusions on usual care 
cannot be made because of the low return of dia-
ries, and the low rate of completion, particularly 
with the control group. Reconsidering how to 
ensure improved diary completion by therapists 
will be vital for future studies.
This was, to our knowledge, the first feasibility 
randomized controlled trial of these orthoses in 
arm rehabilitation after stroke; however, there were 
several limitations. The occupational therapist 
undertaking measurement and prescription was 
trained; however, errors could have occurred. 
Furthermore, limb dimensions often changed 
between first measurement and fitting because of 
oedema onset, and the difference may have caused 
some adverse reactions. The study is limited by 
low retention rates, lack of blinding of healthcare 
professionals and participants, and by assessor 
unblinding. We accounted for baseline severity in 
analysis; however, subgroup analysis based on 
severity would provide more information about 
which survivors might respond best. Because of 
attrition, subgroups were too small to make mean-
ingful conclusions and should be examined in a 
future study. Limited information about wear 
fidelity and usual rehabilitation activities, which 
may both have influenced outcome, should also be 
addressed in future studies. We were primarily 
interested in clinical outcomes in this study; how-
ever, motion analysis with and without the dynamic 
Lycra® is also useful to better understand the effects 
of the orthosis on movement trajectories and to 
inform future orthosis design. We did collect that 
data and will report it in a future publication.
This study indicates that a multicentre rand-
omized controlled trial examining the effects of 
Lycra® orthoses on upper limb impairment and 
activity limitation could be feasible if recruitment 
and retention issues were addressed. However, the 
study underlines the importance of scientifically 
evaluating interventions already in use in clinical 
practice, given that we found skin and circulatory 
problems attributable to the orthoses were problem-
atic. The orthoses may also be detrimental for 
recovery of arm function, possibly acting as rigid 
splints. Thus, assumptions in rehabilitation practice 
and within previous literature, that orthoses act 
dynamically to facilitate movement, can be chal-
lenged. Further research should therefore explore 
precise motor and sensory mechanisms of action. 
Adaptation of orthosis design must also be under-
taken to prevent adverse events and to ensure they 
dynamically facilitate movement and function. 
Progression to full-scale trial is therefore not yet 
warranted.
Clinical messages
•• Adverse reactions in this study were 
high, and retention was difficult and low.
•• There was little indication that Lycra® 
orthoses might benefit arm recovery out-
comes; however, definitive conclusions 
cannot be drawn.
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